Novartis Investigative Site

Vilnius, Vilniaus LT 08661

0 studies enrolling now · 1 studies all time

What they study most

Hidradenitis Suppurativa

Studies at this site

• Study of Efficacy and Safety of Two Secukinumab Dose Regimens in Subjects With Moderate to Severe Hidradenitis Suppurativa (HS) — Completed